What should trials for flu, COVID-19 and RSV measure?
Help PROACT EU-Response define a core outcome set. Patients, carers, regulators and policymakers: take our survey by 31 October. It takes 20 minutes to fill in.
https://t.co/3P4akJV3yu
🔦 #PartnerSpotlight: Meet @eupatientsforum, a PROACT EU-Response partner bringing the patient perspective into pandemic preparedness and clinical research. EPF supports patient involvement across the project, including through our Patient Advisory Group.
Safe care during the next health emergency starts with what we build today.
For #WorldPatientSafetyDay, members of our Patient Advisory Group share what patient safety and patient involvement mean to them.
Read more 👇
https://t.co/kGkEksJBKK
EU-SyndAct combines an innovative platform trial design with patient involvement, looking beyond clinical outcomes to include symptoms, quality of life and patients’ experiences.
🔗 Read more: https://t.co/yMfgtp0c3h
#PROACTEUResponse#ClinicalTrials
PROACT EU-Response’s Patient Advisory Group provides continuous patient input across the project, helping ensure research reflects patients’ needs, priorities and lived experiences, from trial design to preparedness planning.
🤝 Meet the PAG: https://t.co/nOlotWIlNA
💬 “Building strong relationships based on trust and confidence.”
— Prof. Karine Lacombe, PROACT EU-Response Coordinator
Trust and collaboration are key to building a strong European network ready to respond to future health threats.
#PROACTEUResponse#PandemicPreparedness
PROACT EU-Response’s Scientific and Ethics Advisory Board provides independent expertise to guide the project’s research, trial strategy and governance and help prepare Europe for future health emergencies.
Meet the SEAB 👇
https://t.co/sq6mqyUncF
#ResearchEthics
These first achievements demonstrate the power of collaboration, shared expertise and long-term investment in preparedness. Discover PROACT EU-Response with Coordinator Prof. Karine Lacombe: https://t.co/uE3FpvvU2F
🎥 What happens after a health emergency ends? We build on what we've learned. Discover PROACT EU-Response with Coordinator Prof. Karine Lacombe: https://t.co/uE3FpvvU2F #PandemicPreparedness
Last week, the PROACT EU-Response consortium met in Brussels to discuss progress and strengthen preparedness for future infectious disease threats.
Read more: https://t.co/0KqnbWJXlm
🦠 Preparedness starts before the next outbreak.
Today, PROACT EU-Response partners meet in Brussels to strengthen Europe's readiness for future infectious disease threats through collaboration, research, and innovation.
#PandemicPreparedness#ClinicalResearch#PublicHealth
🌍 From crisis response to pandemic preparedness: Europe is getting ready.
What began with #EURESPONSE during COVID-19 is now evolving into #PROACTEUResponse: a long-term effort to strengthen Europe’s readiness for future pandemics.
With 80 clinical centres across 21 countries, adaptive trial platforms, and the integration of social sciences and civil society, the goal is clear: stop reacting, start preparing.
As the world follows the recent hantavirus outbreak linked to the MV Hondius cruise ship, it is a reminder that infectious threats can escalate quickly across borders.
It’s World Immunization Week!
Vaccines protect people across generations, preventing millions of deaths every year.
We support this through:
🔬 Clinical trials
🧪 Immunology networks
📊 Better data for faster responses
🔗 https://t.co/tiipRsso01
#VaccinesWork
Today is International Fact-Checking Day.
Reliable information builds trust, supports evidence-based decisions, and strengthens health crisis response.
Tackling misinformation is essential.
#FactsFirst#HealthPreparedness#FactChecking